ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 58.91 USD -1.54% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
ANI Pharmaceuticals Inc?
Write Note

ANI Pharmaceuticals Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ANI Pharmaceuticals Inc
Net Income (Common) Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Net Income (Common)
$22.9m
CAGR 3-Years
N/A
CAGR 5-Years
6%
CAGR 10-Years
15%
Johnson & Johnson
NYSE:JNJ
Net Income (Common)
$14.7B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income (Common)
-$7.3B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income (Common)
$4.3B
CAGR 3-Years
-40%
CAGR 5-Years
-23%
CAGR 10-Years
-9%
Merck & Co Inc
NYSE:MRK
Net Income (Common)
$12.1B
CAGR 3-Years
19%
CAGR 5-Years
5%
CAGR 10-Years
8%
Eli Lilly and Co
NYSE:LLY
Net Income (Common)
$8.4B
CAGR 3-Years
12%
CAGR 5-Years
1%
CAGR 10-Years
12%

See Also

What is ANI Pharmaceuticals Inc's Net Income (Common)?
Net Income (Common)
22.9m USD

Based on the financial report for Jun 30, 2024, ANI Pharmaceuticals Inc's Net Income (Common) amounts to 22.9m USD.

What is ANI Pharmaceuticals Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
15%

Back to Top